arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Bausch + Lomb Corporation

BLCO Health Care Ophthalmic Goods
$17.43
▲ +3.0% Today
as of Oct 22, 16:46 ET
Last 30 days -0.85% Sep 14 → Oct 22
$15.67 $16.18 $16.70 $17.21 $17.72 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$17.12
High
$17.45
Low
$17.01
Volume
$426,342
Avg Vol
$433,256
Mkt Cap
$6.2B
P/E (TTM)
—
Beta
—
52w High
$18.91
52w Low
$14.44
Div Yield
—
Shares Out
$357M

Recent Press Releases & News last 60 days · 19 items

Oct 22 · 11:00 Benzinga
Billionaire Investor Took a Stake in Bausch + Lomb Before Its CEO Shake-Up
Oct 16 · 16:27 StockStory
3 Reasons BLCO is Risky and 1 Stock to Buy Instead
Oct 12 · 12:09 BioPharma Dive
Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data
▸ Show all 19 press releases & news Free account →

BLCO earnings at a glance

Bausch + Lomb Corporation (BLCO) is scheduled to report earnings on Wednesday, October 28, 2026 before the market opens — in 5 days. Analysts expect earnings per share of $0.21, compared with $0.18 in the same quarter last year (+17%). The options market is pricing a move of about ±8.0% after the report, a range of roughly $16.03 to $18.83 from today's $17.43. Over its last 6 reports the stock rose the next day 1 time and fell 5, moving ±4.9% on average; after the most recent report on Jul 29, 2026 it moved -2.5%. That means options currently expect more movement than BLCO has typically delivered. BLCO beat the consensus EPS estimate in 3 of its last 6 reported quarters. Implied volatility is currently 68%. The share price of $17.43 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$14
$19
67% of range
Avg surprise (last 6)
-46.6%
Avg reaction (last 6)
-4.3%
17% positive
Latest IV / EM
68%
EM ±8.0% · $17 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.48$-0.27$-0.07$0.14$0.35 Actual $-0.26Actual $-0.09Actual $-0.24Actual $-0.48Actual $-0.43Actual $0.01Actual $-0.07Est $0.03Actual $0.07Est $0.06Actual $0.18Est $0.16Actual $0.32Est $0.35Actual $0.08Est $0.06Actual $0.16Est $0.16 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-212M$207M$626M$1.0B$1.5B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 29, 2026Jun/2026 $0.16 $0.16 0.0% +128.6% -2.5% earnings
Wed Apr 29, 20268K 2026-04-29 $0.08 $0.06 +33.3% — -2.4% earnings
Wed Feb 18, 20268K 2026-02-18 $0.32 $0.35 -8.6% — -0.3% earnings
Wed Oct 29, 2025Sep/2025 $0.18 $0.16 +12.5% — +1.8% earnings
Wed Jul 30, 2025Jun/2025 $0.07 $0.06 +16.7% — -6.4% earnings
Wed Apr 30, 2025Mar/2025 $-0.07 $0.03 -333.3% — -15.7% earnings
Mon Sep 30, 2024Sep 2024 $0.01 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.43 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.48 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.24 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.09 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.26 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Oct 28, 2026Sep/2026BMO $0.21$0.18 +16.7%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.39B$1.24B—$1.28B$1.28B$1.14B—$1.20B
Cost of revenue————————
Gross profit————————
Operating income$83M$33M—$95M$-11M$-83M—$43M
Net income$-14M$-71M—$-28M$-62M$-212M—$4M
EPS (diluted)$-0.04$-0.20—$-0.08$-0.18$-0.60—$0.01

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$367M$268M$383M$310M$266M$202M$305M$329M
Inventory$999M$977M$976M$1.00B$1.05B$1.03B$1.04B$1.12B
Total current assets$2.92B$2.78B$2.98B$2.85B$2.85B$2.69B$2.79B$2.83B
Total assets$13.86B$13.78B$14.02B$13.83B$13.83B$13.43B$13.47B$13.52B
Long-term debt$5.05B$5.01B$5.02B$4.92B$4.93B$4.79B$4.74B$4.60B
Total liabilities$7.42B$7.33B$7.50B$7.33B$7.32B$7.00B$6.92B$6.85B
Total equity$6.38B$6.45B$6.45B$6.43B$6.51B$6.43B$6.47B$6.66B

Implied volatility — last 90 days

33%61%89%117%145% Jun 09 — IV 54% · EM ±6.7%Jun 10 — IV 73% · EM ±8.6%Jun 11 — IV 86% · EM ±9.5%Jun 12 — IV 84% · EM ±8.6%Jun 15 — IV 78% · EM ±5.7%Jun 16 — IV 96% · EM ±5.7%Jun 22 — IV 43% · EM ±9.0%Jun 23 — IV 46% · EM ±9.5%Jun 24 — IV 35% · EM ±7.1%Jun 25 — IV 39% · EM ±7.7%Jun 26 — IV 69% · EM ±13.2%Jun 29 — IV 56% · EM ±9.9%Jun 30 — IV 110% · EM ±18.9%Jul 01 — IV 62% · EM ±10.4%Jul 02 — IV 61% · EM ±9.9%Jul 03 — IV 63% · EM ±9.9%Jul 06 — IV 49% · EM ±6.7%Jul 07 — IV 100% · EM ±13.2%Jul 08 — IV 61% · EM ±7.7%Jul 09 — IV 76% · EM ±9.0%Jul 10 — IV 81% · EM ±8.9%Jul 13 — IV 114% · EM ±9.6%Jul 15 — IV 120% · EM ±7.1%Jul 20 — IV 51% · EM ±12.0%Jul 21 — IV 69% · EM ±16.1%Jul 22 — IV 53% · EM ±12.2%Jul 23 — IV 45% · EM ±10.2%Jul 24 — IV 55% · EM ±12.2%Jul 27 — IV 61% · EM ±12.7%Jul 28 — IV 57% · EM ±11.7%Jul 29 — IV 63% · EM ±12.7%Jul 30 — IV 41% · EM ±7.9%Jul 31 — IV 46% · EM ±8.7%Aug 03 — IV 49% · EM ±8.6%Aug 04 — IV 46% · EM ±7.9%Aug 05 — IV 56% · EM ±9.4%Aug 06 — IV 54% · EM ±8.7%Aug 07 — IV 46% · EM ±7.2%Aug 10 — IV 73% · EM ±10.1%Aug 11 — IV 72% · EM ±9.5%Aug 12 — IV 64% · EM ±8.1%Aug 13 — IV 70% · EM ±8.2%Aug 14 — IV 57% · EM ±6.3%Aug 17 — IV 63% · EM ±5.3%Aug 18 — IV 87% · EM ±6.3%Aug 19 — IV 146% · EM ±8.6%Aug 20 — IV 111% · EM ±4.7%Aug 24 — IV 44% · EM ±9.2%Aug 25 — IV 35% · EM ±7.1%Aug 26 — IV 33% · EM ±6.7%Aug 27 — IV 46% · EM ±9.0%Aug 28 — IV 44% · EM ±8.5%Aug 31 — IV 52% · EM ±9.2%Sep 01 — IV 39% · EM ±6.7%Sep 02 — IV 43% · EM ±7.2%Sep 03 — IV 41% · EM ±6.6%Sep 04 — IV 110% · EM ±17.2%Sep 07 — IV 124% · EM ±17.2%Sep 08 — IV 41% · EM ±5.4%Sep 09 — IV 52% · EM ±6.5%Sep 10 — IV 39% · EM ±4.6%Sep 11 — IV 92% · EM ±10.1%Sep 14 — IV 77% · EM ±6.4%Sep 15 — IV 84% · EM ±6.1%Sep 16 — IV 84% · EM ±5.0%Sep 17 — IV 119% · EM ±5.0%Sep 21 — IV 47% · EM ±9.8%Sep 22 — IV 42% · EM ±8.5%Sep 23 — IV 54% · EM ±10.8%Sep 24 — IV 43% · EM ±8.3%Sep 25 — IV 46% · EM ±8.7%Sep 28 — IV 51% · EM ±9.0%Sep 29 — IV 47% · EM ±8.0%Sep 30 — IV 58% · EM ±9.7%Oct 01 — IV 45% · EM ±7.2%Oct 02 — IV 50% · EM ±7.7%Oct 06 — IV 55% · EM ±7.3%Oct 07 — IV 99% · EM ±12.4%Oct 08 — IV 68% · EM ±8.0%

Sector peers

WRBY
Warby Parker Inc.
$3.1B $25.67+0.2%
EYE
National Vision Holdings, Inc.
$1.3B $18.87+5.1%
STAA
STAAR Surgical Company
$1.1B $22.49+0.8%
RXST
RxSight, Inc.
$200M $5.08+4.1%
LUCY
Innovative Eyewear, Inc.
$8M $0.86+3.6%
COO
The Cooper Companies, Inc.
$13.6B $61.65+4.3%

BLCO earnings FAQ

When is BLCO's next earnings date?

Bausch + Lomb Corporation is expected to report on October 28, 2026, before the market opens.

What is BLCO's expected move for earnings?

Options currently price a move of about ±8.0%, or $1.40 per share either way from $17.43.

How does BLCO stock usually react to earnings?

Across the last 6 reports the average next-day move was ±4.9%, up 1 times and down 5 times.

What EPS are analysts expecting from Bausch + Lomb Corporation?

The consensus estimate is $0.21 per share, versus $0.18 a year ago.

What is BLCO's implied volatility?

BLCO's at-the-money implied volatility is about 68% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in